PAK2 and prostate carcinoma: In prostate cancer, csHSPA5 binds to α2-macroglobulin (α2M), a known proteinase inhibitor, to phosphorylate and activate PAK-2, a known mediator of angiogenesis, migration, and metastasis [95].